Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Parenteral isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Oral isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Modified release isosorbide dinitrate adverse reaction |
Causative agent (attribute) |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
allergie au dinitrate d'isosorbide |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Parenteral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Oral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate overdose (disorder) |
Causative agent (attribute) |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 5mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
dinitrate d'isosorbide 500 microgrammes/mL, fiole de 50 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 1.25 mg/actuation sublingual spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 30mg transdermal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
dinitrate d'isosorbide 1 mg/mL, ampoule de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
dinitrate d'isosorbide 1 mg/mL, fiole de 50 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Modified release isosorbide dinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Transdermal isosorbide dinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 40mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing precisely isosorbide dinitrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate in sublingual dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Isosorbide dinitrate 5 mg sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Product containing isosorbide dinitrate in oropharyngeal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
|
Oral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
allergie au dinitrate d'isosorbide |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Modified release isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Parenteral isosorbide dinitrate allergy |
Causative agent (attribute) |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 1.25 mg/actuation sublingual spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 1.25 mg/actuation sublingual spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 30 mg/actuation transdermal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 30 mg/actuation transdermal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 10 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 10 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 50 milligram/50 milliliter conventional release solution for injection bottle |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 50 milligram/50 milliliter conventional release solution for injection bottle |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 25 milligram/50 milliliter conventional release solution for injection bottle |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 25 milligram/50 milliliter conventional release solution for injection bottle |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 1 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 1 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 5 mg sublingual tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate 5 mg sublingual tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isosorbide dinitrate 2.5 milligram/1 each conventional release sublingual tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Product containing only isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Product containing hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Product containing only hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Hydralazine- and isosorbide dinitrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
2 |
Isosorbide dinitrate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |
Isosorbide dinitrate only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isosorbide dinitrate (substance) |
Inferred relationship |
Some |
1 |